536602929	536602929	CD	B-NP	O
|	|	NN	I-NP	O
IH	IH	NN	I-NP	O
|	|	NN	I-NP	O
92216952	92216952	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5279301	5279301	CD	B-NP	O
|	|	CC	I-NP	O
2/7/2007	2/7/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Asthma	Asthma	NNP	I-NP	I-protein
flair	flair	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/7/2007	10/7/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/26/2007	8/26/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LOUNSBERY	LOUNSBERY	NNP	B-NP	O
,	,	,	O	O
KEN	KEN	NNP	B-NP	O
J	J	NNP	I-NP	O
250-82-35-0	250-82-35-0	CD	I-NP	O
Stocktaseyty	Stocktaseyty	NNP	I-NP	O
Ter	Ter	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/11/07	7/11/07	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DORNBUSCH	DORNBUSCH	NN	B-NP	O
,	,	,	O	O
HAI	HAI	NNP	B-NP	O
BROOKS	BROOKS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ALBUTEROL	ALBUTEROL	NN	B-NP	O
AND	AND	CC	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	B-protein
NEBULIZER	NEBULIZER	NN	I-NP	I-protein
3/0	3/0	CD	I-NP	I-protein
.5	.5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
NEB	NEB	NN	I-NP	I-protein
Q4H	Q4H	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

ALBUTEROL	ALBUTEROL	NN	B-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q2H	Q2H	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

DIVALPROEX	DIVALPROEX	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

DOCUSATE	DOCUSATE	JJ	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

INSULIN	INSULIN	NNP	B-NP	B-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
26	26	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

INSULIN	INSULIN	NN	B-NP	B-protein
REGULAR	REGULAR	NN	I-NP	I-protein
HUMAN	HUMAN	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

LACTULOSE	LACTULOSE	NN	B-NP	O
15-30	15-30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
QID	QID	NN	I-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

OXYCODONE	OXYCODONE	NN	B-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

PREDNISONE	PREDNISONE	NN	B-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

RISPERIDONE	RISPERIDONE	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
13	13	CD	I-NP	I-protein
.	.	.	O	O

SENNOSIDES	SENNOSIDES	NNS	B-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

TRAZODONE	TRAZODONE	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
HS	HS	NNP	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

ABILIFY	ABILIFY	NNP	B-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

INSULIN	INSULIN	NN	B-NP	B-protein
SYRINGES	SYRINGES	NNS	I-NP	I-protein
1	1	CD	I-NP	I-protein
CC	CC	NN	I-NP	I-protein
SC	SC	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
17	17	CD	I-NP	I-protein
.	.	.	O	O

ONE	ONE	NNP	B-NP	O
TOUCH	TOUCH	NNP	I-NP	O
ULTRA	ULTRA	NNP	I-NP	O
SOFT	SOFT	NNP	I-NP	O
LANCETS	LANCETS	NNP	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

ONE	ONE	NNP	B-NP	O
TOUCH	TOUCH	NNP	I-NP	O
ULTRA	ULTRA	NNP	I-NP	O
TEST	TEST	NNP	I-NP	O
STRIPS	STRIPS	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	O
AND	AND	CC	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q2H	Q2H	NN	I-NP	O
ZYRTEC	ZYRTEC	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CETIRIZINE	CETIRIZINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DEPAKOTE	DEPAKOTE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
DIVALPROEX	DIVALPROEX	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PEPCID	PEPCID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FAMOTIDINE	FAMOTIDINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/10/07	8/10/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
OMEPRAZOLE	OMEPRAZOLE	NNP	B-NP	O
&	&	CC	I-NP	O
FAMOTIDINE	FAMOTIDINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Omeprazole	Omeprazole	NN	B-NP	B-protein
discontinued	discontinue	VBD	B-VP	I-protein
FLONASE	FLONASE	NNP	B-NP	I-protein
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
sprays	spray	NNS	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
nostril	nostril	NN	I-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
ADVAIR	ADVAIR	NN	I-NP	O
DISKUS	DISKUS	VBZ	B-VP	O
500/50	500/50	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	I-protein
12.5	12.5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
28	28	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
February	February	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
If	If	IN	B-SBAR	O
not	not	RB	B-VP	O
eating	eat	VBG	I-VP	O
take	take	VB	B-VP	O
half	half	JJ	B-NP	O
dose	dose	NN	I-NP	O
INSULIN	INSULIN	NN	I-NP	O
REGULAR	REGULAR	NN	I-NP	O
HUMAN	HUMAN	NN	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LACTULOSE	LACTULOSE	NNP	I-NP	O
30	30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/19/07	11/19/07	CD	B-NP	O
by	by	IN	B-PP	O
CASSIANO	CASSIANO	NN	B-NP	O
,	,	,	O	O
ERIN	ERIN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
326936931	326936931	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
OXYCODONE	OXYCODONE	NNP	B-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
60	60	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
24	24	CD	I-NP	I-protein
h	h	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
2	2	CD	I-NP	I-protein
dose	dose	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Starting	Starting	NNP	B-NP	O
Today	Today	NNP	I-NP	O
November	November	NNP	I-NP	O
RISPERDAL	RISPERDAL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RISPERIDONE	RISPERIDONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3	3	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
TRAZODONE	TRAZODONE	NN	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	I-protein
ABILIFY	ABILIFY	NNP	I-NP	I-protein
15	15	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Marlon	Marlon	NNP	I-NP	O
Hegge	Hegge	NNP	I-NP	O
PCP	PCP	NN	I-NP	O
phone	phone	NN	I-NP	O
498-674-2301	498-674-2301	CD	I-NP	O
11/1	11/1	CD	I-NP	O
at	at	IN	B-PP	O
noon	noon	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Chauhdrey	Chauhdrey	NNP	I-NP	O
Psych	Psych	NNP	I-NP	O
6/12	6/12	CD	I-NP	O
at	at	IN	B-PP	O
10am	10am	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Autrano	Autrano	NNP	I-NP	O
Pulmonology	Pulmonology	NNP	I-NP	O
phone	phone	NN	I-NP	O
234-865-1925	234-865-1925	CD	I-NP	O
10/25	10/25	CD	I-NP	O
at	at	IN	B-PP	O
1pm	1pm	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
Function	Function	NNP	I-NP	O
Testing	Testing	NNP	I-NP	O
phone	phone	NN	I-NP	O
994.651.6338	994.651.6338	CD	I-NP	O
10/25	10/25	CD	I-NP	O
at	at	IN	B-PP	O
11am	11am	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
NSAIDs	NSAIDs	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
ACETAMINOPHEN	ACETAMINOPHEN	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
asthma	asthma	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Asthma	Asthma	NNP	I-NP	O
flair	flair	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
NSVD	NSVD	NNP	I-NP	O
x	x	CC	O	O
4	4	CD	B-NP	O
Asthma	Asthma	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
~	~	NN	I-NP	O
15	15	CD	B-NP	O
intubations	intubation	NNS	I-NP	O
-LRB-	-LRB-	JJ	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
vocal	vocal	JJ	I-NP	O
cord	cord	NN	I-NP	O
dysfunction-Addunction	dysfunction-Addunction	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
schizoaffective	schizoaffective	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
bipolar	bipolar	JJ	I-NP	O
subtype	subtype	NN	I-NP	O
morbid	morbid	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sleep	Sleep	NNP	I-NP	O
Apnea	Apnea	NNP	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
see	see	VB	B-VP	O
discharge	discharge	NN	B-NP	O
summary	summary	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
see	see	VBP	B-VP	O
discharge	discharge	NN	B-NP	O
summary	summary	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
33	33	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
s/p	s/p	NN	I-NP	O
15	15	CD	B-NP	O
intubations	intubation	NNS	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
11/23/07	11/23/07	CD	B-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
5	5	CD	I-NP	O
days	day	NNS	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
asthma	asthma	NN	I-NP	O
flair	flair	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
fine	fine	JJ	B-ADJP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
initially	initially	RB	B-ADVP	O
but	but	CC	O	O
that	that	DT	B-NP	O
by	by	IN	B-PP	O
Saturday	Saturday	NNP	B-NP	O
evening	evening	NN	I-NP	O
approx	approx	NN	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
noted	note	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
gradual	gradual	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
was	be	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
approx	approx	NN	I-NP	O
9/10	9/10	CD	I-NP	O
in	in	IN	B-PP	O
severity	severity	NN	B-NP	O
without	without	IN	B-PP	O
radiation	radiation	NN	B-NP	O
and	and	CC	O	O
worse	worse	JJR	B-ADJP	O
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
or	or	CC	I-NP	O
inspiratory	inspiratory	JJ	I-NP	O
effort	effort	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
abate	abate	VB	I-VP	O
despite	despite	IN	B-PP	O
constant	constant	JJ	B-NP	O
albuterol	albuterol	NN	I-NP	O
nebs	neb	NNS	I-NP	O
and	and	CC	O	O
taking	take	VBG	B-VP	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Prednisone	Prednisone	NN	B-NP	O
60mg	60mg	NN	I-NP	O
that	that	IN	B-NP	O
morning	morning	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
peak	peak	NN	I-NP	O
flow	flow	NN	I-NP	O
was	be	VBD	B-VP	O
300	300	CD	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
is	be	VBZ	B-VP	O
500	500	CD	B-NP	O
.	.	.	O	O

Consequently	Consequently	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SSNMC	SSNMC	NN	I-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
short	short	JJ	I-NP	O
interim	interim	NN	I-NP	O
since	since	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
she	she	PRP	B-NP	O
reports	report	VBZ	B-VP	O
being	be	VBG	I-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
stayed	stay	VBD	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
interval	interval	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
clear	clear	JJ	I-NP	O
precipitating	precipitate	VBG	I-NP	O
trigger	trigger	NN	I-NP	O
including	include	VBG	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
cold	cold	JJ	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
URI	URI	NN	B-NP	B-protein
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
irritants	irritant	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
cleaning	clean	VBG	B-VP	O
products	product	NNS	B-NP	O
or	or	CC	I-NP	O
perfumes	perfume	NNS	I-NP	O
or	or	CC	O	O
significant	significant	JJ	B-NP	O
emotional	emotional	JJ	I-NP	O
stress	stress	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
carpets	carpet	NNS	I-NP	O
cleaned	clean	VBN	B-VP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
15	15	CD	I-NP	O
intubations	intubation	NNS	I-NP	O
,	,	,	O	O
Last	Last	JJ	B-NP	O
intubation	intubation	NN	I-NP	O
last	last	JJ	B-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
age	age	NN	B-NP	O
12	12	CD	I-NP	O
,	,	,	I-NP	O
10	10	CD	I-NP	O
+	+	SYM	I-NP	O
flares/year	flares/year	NN	I-NP	O
requiring	require	VBG	B-VP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2005	2005	CD	B-NP	O
PFT	PFT	NN	I-NP	O
FEV1	FEV1	NN	I-NP	O
90s	90	NNS	I-NP	O
,	,	,	O	O
FVC	FVC	NNP	B-NP	O
90	90	CD	I-NP	O
,	,	,	O	O
FEV/FVC90	FEV/FVC90	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

IDDM	IDDM	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Schizoaffective	Schizoaffective	JJ	B-NP	O
d/o	d/o	NN	I-NP	O
bipolar	bipolar	JJ	I-NP	O
subtype	subtype	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Morbid	Morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

laryngeal	laryngeal	JJ	B-NP	O
adduction	adduction	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

TTE	TTE	NN	B-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
2005	2005	CD	B-NP	O
PSH	PSH	NN	I-NP	B-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Appendectomy	Appendectomy	NN	B-NP	O
2003	2003	CD	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

C-section	C-section	NN	B-NP	O
1997	1997	CD	I-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NSAIDs	NSAID	NNS	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
-	-	HYPH	I-NP	O
angioedema	angioedema	NN	I-NP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
-	-	HYPH	I-NP	O
hives	hive	NNS	I-NP	O
,	,	,	O	O
PCN	PCN	NN	B-NP	B-protein
-	-	HYPH	O	O
hives	hive	VBZ	B-VP	O
Meds	Med	NNS	B-NP	O
on	on	IN	B-PP	O
Admission	Admission	NN	B-NP	O
:	:	:	O	O
DUONEB	DUONEB	NN	B-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
,	,	,	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
Q2H	Q2H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
SOB	SOB	NN	I-NP	I-protein
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
,	,	,	O	O
DEPAKOTE	DEPAKOTE	NNP	B-NP	O
500Mg	500Mg	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NNP	B-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
OXYCODONE	OXYCODONE	NNP	B-NP	O
10MG	10MG	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
PREDNISONE	PREDNISONE	NNP	B-NP	O
60MG	60MG	NNP	I-NP	O
qd	qd	NN	I-NP	O
taper	taper	NN	I-NP	O
,	,	,	O	O
RISPERDAL	RISPERDAL	NN	B-NP	O
3MG	3MG	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
INSULIN	INSULIN	NNP	B-NP	B-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
26	26	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
INSULIN	INSULIN	NNP	B-NP	B-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
LACTULOSE	LACTULOSE	NNP	B-NP	O
15-30ML	15-30ML	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
,	,	,	O	O
TRAZODONE	TRAZODONE	NNP	B-NP	O
300MG	300MG	NNP	I-NP	O
qHS	qHS	NNP	I-NP	O
,	,	,	O	O
ABILIFY	ABILIFY	NNP	B-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
qHS	qHS	NNP	I-NP	O
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
20mg	20mg	NNP	I-NP	O
qd	qd	NNP	I-NP	O
,	,	,	O	O
Senna/Colace	Senna/Colace	NNP	B-NP	O
Meds	Med	NNPS	I-NP	O
on	on	IN	B-PP	O
Discharge	Discharge	NNP	B-NP	O
DUONEB	DUONEB	NNP	I-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
,	,	,	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
Q2H	Q2H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
SOB	SOB	NN	I-NP	I-protein
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
,	,	,	O	O
DEPAKOTE	DEPAKOTE	NNP	B-NP	O
500Mg	500Mg	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NNP	B-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
OXYCODONE	OXYCODONE	NNP	B-NP	O
10MG	10MG	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
PREDNISONE	PREDNISONE	NNP	B-NP	O
60MG	60MG	NNP	I-NP	O
qd	qd	NN	I-NP	O
taper	taper	NN	I-NP	O
,	,	,	O	O
RISPERDAL	RISPERDAL	NN	B-NP	O
3MG	3MG	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
INSULIN	INSULIN	NNP	B-NP	B-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
26	26	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
INSULIN	INSULIN	NNP	B-NP	B-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
LACTULOSE	LACTULOSE	NNP	B-NP	O
15-30ML	15-30ML	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
,	,	,	O	O
TRAZODONE	TRAZODONE	NNP	B-NP	O
300MG	300MG	NNP	I-NP	O
qHS	qHS	NNP	I-NP	O
,	,	,	O	O
ABILIFY	ABILIFY	NNP	B-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
qHS	qHS	NNP	I-NP	O
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
20mg	20mg	NNP	I-NP	O
qd	qd	NNP	I-NP	O
,	,	,	O	O
Senna/Colace	Senna/Colace	NNP	B-NP	O
,	,	,	O	O
Singulair	Singulair	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
qd	qd	NNP	I-NP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
INH	INH	NNP	I-NP	O
500/50	500/50	CD	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	I-NP	O
Zyrtec	Zyrtec	NNP	I-NP	O
10mg	10mg	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Flonase	Flonase	NN	B-NP	B-protein
Nasal	Nasal	JJ	I-NP	I-protein
Spray	Spray	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
puffs	puff	NNS	I-NP	I-protein
in	in	IN	B-PP	O
each	each	DT	B-NP	O
nostril	nostril	NN	I-NP	O
qd	qd	NN	I-NP	O
Physical	Physical	NNP	I-NP	O
Exam	Exam	NNP	I-NP	O
Tm/c	Tm/c	NNP	I-NP	O
97.9	97.9	CD	I-NP	O
/	/	SYM	O	O
97.1	97.1	CD	B-NP	O
HR	HR	NN	I-NP	O
85-95	85-95	CD	B-NP	O
BP	BP	NN	I-NP	O
94-114/50	94-114/50	CD	B-NP	O
-60	-60	CD	I-NP	O
RR	RR	NN	I-NP	O
18	18	CD	B-NP	O
O2Sat	O2Sat	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NNP	B-NP	O
General	General	NNP	I-NP	O
:	:	:	O	O
Morbidly	Morbidly	RB	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
lying	lie	VBG	B-VP	O
comfortably	comfortably	RB	B-ADVP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
speak	speak	VB	I-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
NCAT	NCAT	NN	B-NP	B-protein
.	.	.	O	O

PERRLA	PERRLA	NN	B-NP	O
at	at	IN	B-PP	O
3mm	3mm	NN	B-NP	O
,	,	,	O	O
VFFC	VFFC	NN	B-NP	B-protein
,	,	,	O	O
sclera	sclera	NN	B-NP	O
anicteric	anicteric	NN	I-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
without	without	IN	B-PP	O
erythema	erythema	NN	B-NP	O
,	,	,	O	O
exudates	exudate	NNS	B-NP	O
or	or	CC	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
moist	moist	NN	I-NP	O
Neck	Neck	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
noted	note	VBD	B-VP	O
.	.	.	O	O

Trachea	Trachea	NNP	B-NP	O
midline	midline	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

Thyroid	Thyroid	NN	B-NP	O
not	not	RB	O	O
enlarged	enlarge	VBN	B-VP	O
and	and	CC	O	O
without	without	IN	B-PP	O
nodules	nodule	NNS	B-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
.	.	.	O	O

nl	nl	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
MGR	MGR	NN	I-NP	B-protein
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
5cm	5cm	CD	B-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
Distant	Distant	JJ	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
equal	equal	JJ	B-NP	O
b/l	b/l	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
were	be	VBD	B-VP	O
heard	hear	VBN	I-VP	O
.	.	.	O	O

Not	Not	RB	O	O
using	use	VBG	B-VP	O
accessory	accessory	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
for	for	IN	B-PP	O
respiration	respiration	NN	B-NP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	O
:	:	:	O	O
NTND	NTND	NNP	B-NP	O
,	,	,	O	O
NABS	NABS	NNP	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
HSM	HSM	NN	I-NP	B-protein
.	.	.	O	O

Well	Well	NNP	B-NP	O
healed	heal	VBD	B-VP	O
surgical	surgical	JJ	B-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

Spine/Ext	Spine/Ext	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
vertebral	vertebral	JJ	I-NP	O
or	or	CC	I-NP	O
paravertebral	paravertebral	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

DPs	DP	NNS	B-NP	B-protein
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-ADJP	O
throughout	throughout	IN	B-PP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
CCE	CCE	NN	I-NP	O
Neuro	Neuro	NNP	I-NP	O
:	:	:	O	O
CN	CN	NN	B-NP	O
II-XII	II-XII	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Motor	Motor	NN	B-NP	B-protein
-5	-5	CD	I-NP	I-protein
/	/	SYM	I-NP	O
5	5	CD	I-NP	O
throughout	throughout	RB	I-NP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
:	:	:	O	O
Symmetric	Symmetric	JJ	B-ADJP	O
to	to	TO	B-PP	O
PP	PP	NN	B-NP	B-protein
,	,	,	I-NP	O
temp	temp	NN	I-NP	O
and	and	CC	I-NP	O
vibration	vibration	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Proprioception	Proprioception	NN	B-NP	O
is	be	VBZ	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Coordination	Coordination	NNP	B-NP	O
is	be	VBZ	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

DTRs	DTR	NNS	B-NP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

MS	MS	NN	B-NP	B-protein
AOx	AOx	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Imaging	Image	VBG	B-VP	O
1	1	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
radiograph	radiograph	NN	I-NP	O
:	:	:	O	O
normal	normal	JJ	B-NP	O
study	study	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
previous	previous	JJ	I-NP	O
studies	study	NNS	I-NP	O
2	2	CD	B-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
suboptimal	suboptimal	JJ	B-NP	O
study	study	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
central	central	JJ	B-NP	O
PE	PE	NN	I-NP	O
or	or	CC	O	O
large	large	JJ	B-NP	O
DVT	DVT	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulm	Pulm	NNP	B-NP	O
:	:	:	O	O
H/o	H/o	NNP	B-NP	O
severe	severe	JJ	I-NP	O
asthma	asthma	NN	I-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
readmitted	readmitte	VBN	B-VP	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
worsneing	worsnee	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
despite	despite	IN	B-PP	O
being	be	VBG	B-VP	O
on	on	IN	B-PP	O
Prednisone	Prednisone	NN	B-NP	O
60mg	60mg	NN	I-NP	O
qd	qd	NN	I-NP	O
and	and	CC	O	O
Albuteral	Albuteral	JJ	B-NP	B-protein
Nebs	Neb	NNS	I-NP	I-protein
.	.	.	O	O

Acutely	Acutely	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
tachypnea	tachypnea	NN	B-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
02	02	CD	I-NP	O
sats	sat	NNS	I-NP	O
,	,	,	O	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
accessory	accessory	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
for	for	IN	B-PP	O
inspiration	inspiration	NN	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Triggers	Trigger	NNS	B-NP	O
were	be	VBD	B-VP	O
reviewed	review	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
precipitating	precipitating	NN	I-NP	O
triggers	trigger	VBZ	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
flare	flare	NN	I-NP	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
carpet	carpet	NN	B-NP	O
cleaning	cleaning	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
solumedrol	solumedrol	NN	B-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
dose	dose	NN	I-NP	O
then	then	RB	B-ADVP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
prednisone	prednisone	NN	B-NP	O
.	.	.	O	O

Breath	Breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
diminished	diminish	VBN	I-VP	O
but	but	CC	O	O
no	no	DT	B-NP	O
wheezing	wheezing	NN	I-NP	O
was	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
duoneb	duoneb	NN	B-NP	O
and	and	CC	I-NP	O
albuterol	albuterol	NN	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
for	for	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Singulair	Singulair	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
maximum	maximum	NN	B-NP	O
possible	possible	JJ	I-NP	O
pharmacological	pharmacological	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
outpatient	outpatient	NN	I-NP	O
pulmonologist	pulmonologist	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
,	,	,	O	O
recommended	recommend	VBD	B-VP	O
continued	continue	VBN	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
and	and	CC	I-NP	O
outpatient	outpatient	NN	I-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
including	include	VBG	B-PP	O
PFTs	PFT	NNS	B-NP	B-protein
.	.	.	O	O

Peak	Peak	NN	B-NP	O
flows	flow	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
from	from	IN	B-PP	O
300	300	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
530	530	CD	B-NP	I-DNA
on	on	IN	B-PP	O
Hospital	Hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Arrangements	Arrangement	NNS	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
CPAP	CPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
for	for	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
Pulmonary	Pulmonary	JJ	B-ADJP	O
follow	follow	VB	B-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
start	start	VB	I-VP	O
zyrtec	zyrtec	NN	B-NP	O
and	and	CC	I-NP	O
flonase	flonase	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
allergic	allergic	JJ	I-NP	O
component	component	NN	I-NP	O
to	to	TO	B-PP	O
asthma	asthma	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
PPD	PPD	NN	I-NP	B-protein
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Lisinopril	Lisinopril	NNP	B-NP	O
and	and	CC	O	O
HCTZ	HCTZ	NN	B-NP	B-protein
for	for	IN	B-PP	O
BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
routine	routine	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
exam	exam	NN	I-NP	O
and	and	CC	O	O
nothing	nothing	NN	B-NP	O
to	to	TO	B-VP	O
suggest	suggest	VB	I-VP	O
cardiac	cardiac	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

CP	CP	NN	B-NP	B-DNA
appeared	appear	VBD	B-VP	O
musculoskeletal	musculoskeletal	JJ	B-ADJP	O
in	in	IN	B-PP	O
origin	origin	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
all	all	DT	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
schizoaffective	schizoaffective	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
appointment	appointment	NN	I-NP	O
for	for	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
psychiatrist	psychiatrist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Fraunfelter	Fraunfelter	NNP	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

ADA	ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Replete	Replete	JJ	B-NP	B-protein
K	K	NN	I-NP	I-protein
and	and	CC	O	O
MG	MG	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
Lovenox	Lovenox	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
while	while	IN	B-SBAR	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	B-protein
7	7	CD	B-NP	I-protein
.	.	.	O	O

Code	Code	NN	B-NP	O
:	:	:	O	O
full	full	JJ	B-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
:	:	:	O	O
home	home	NN	B-ADVP	O
Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
left	leave	VBD	B-VP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
receiving	receive	VBG	B-VP	O
discharge	discharge	NN	B-NP	O
paperworka	paperworka	NN	I-NP	O
nd	nd	NN	I-NP	O
prescriptions	prescription	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Your	Your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
changed	change	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
ways	way	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
3	3	CD	B-NP	O
new	new	JJ	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Zyrtec	Zyrtec	NN	B-NP	B-cell_type
to	to	TO	B-VP	O
take	take	VB	I-VP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
flonase	flonase	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
once	once	IN	B-SBAR	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pepcid	pepcid	NN	B-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Your	Your	PRP$	B-NP	O
NPH	NPH	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
26	26	CD	B-NP	O
units	unit	NNS	I-NP	O
to	to	TO	B-PP	O
28	28	CD	B-NP	O
units	unit	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
adjustments	adjustment	NNS	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Continue	Continue	VB	B-VP	O
the	the	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
that	that	IN	B-NP	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

While	While	IN	B-SBAR	O
on	on	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
take	take	VB	I-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
constipation	constipation	NN	B-NP	O
including	include	VBG	B-PP	O
colace	colace	NN	B-NP	O
and	and	CC	I-NP	O
lactulose	lactulose	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Continue	Continue	VB	B-VP	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

*	*	SYM	O	O
Please	Please	NN	B-NP	B-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rosenburg	Rosenburg	NNP	I-NP	O
.	.	.	O	O

Obtain	Obtain	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
,	,	,	O	O
*	*	SYM	B-NP	O
Please	Please	NN	I-NP	B-protein
seek	seek	VBP	B-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
for	for	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
resume	resume	VB	I-VP	O
her	her	PRP	B-NP	O
Advair	Advair	NNP	I-NP	O
inhaler	inhaler	NN	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
finishes	finish	VBZ	B-VP	O
her	her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
steroid	steroid	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonology	Pulmonology	NNP	B-NP	O
:	:	:	O	O
Appt	Appt	NNP	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rideaux	Rideaux	NNP	I-NP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
PFTs	PFT	NNS	I-NP	O
scheduled	schedule	VBN	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
visit	visit	VB	I-VP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
make	make	VB	I-VP	O
recommendations	recommendation	NNS	B-NP	O
for	for	IN	B-PP	O
disease	disease	NN	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
patient	patient	NN	B-NP	O
after	after	IN	B-PP	O
steroid	steroid	NN	B-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

Management	Management	NN	B-NP	O
of	of	IN	B-PP	O
DM	DM	NN	B-NP	O
and	and	CC	I-NP	O
HTN	HTN	NN	I-NP	B-protein
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
emphasize	emphasize	VBP	B-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
weight-loss	weight-loss	NN	B-NP	O
and	and	CC	I-NP	O
life	life	NN	I-NP	O
style	style	NN	I-NP	O
modification	modification	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Psych	Psych	NNP	B-NP	O
Please	Please	NNP	I-NP	O
manage	manage	NN	I-NP	O
schizoaffective	schizoaffective	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
consider	consider	VB	I-VP	O
ativan	ativan	NN	B-NP	O
prn	prn	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
we	we	PRP	B-NP	O
consider	consider	VBP	B-VP	O
anxiety	anxiety	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
be	be	VB	I-NP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
trigger	trigger	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
respiratory	respiratory	JJ	I-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
JAIN	JAIN	NNP	B-NP	O
,	,	,	O	O
LOREN	LOREN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CB420	CB420	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/11/07	7/11/07	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
05	05	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

